161 related articles for article (PubMed ID: 17988845)
1. EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro.
Doliana R; Veljkovic V; Prljic J; Veljkovic N; De Lorenzo E; Mongiat M; Ligresti G; Marastoni S; Colombatti A
Matrix Biol; 2008 Mar; 27(2):96-106. PubMed ID: 17988845
[TBL] [Abstract][Full Text] [Related]
2. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
[TBL] [Abstract][Full Text] [Related]
3. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
Gupta P; Singh A; Chauhan V; Bhatnagar R
Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen.
Ahuja N; Kumar P; Bhatnagar R
Biochem Biophys Res Commun; 2001 Sep; 287(2):542-9. PubMed ID: 11554763
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
6. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
[TBL] [Abstract][Full Text] [Related]
7. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
Young JA; Collier RJ
Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
[TBL] [Abstract][Full Text] [Related]
8. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
[TBL] [Abstract][Full Text] [Related]
9. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
[TBL] [Abstract][Full Text] [Related]
11. Participation of residue F552 in domain III of the protective antigen in the biological activity of anthrax lethal toxin.
Khanna H; Gupta PK; Singh A; Chandra R; Singh Y
Biol Chem; 2001 Jun; 382(6):941-6. PubMed ID: 11501759
[TBL] [Abstract][Full Text] [Related]
12. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
Maldonado-Arocho FJ; Fulcher JA; Lee B; Bradley KA
Mol Microbiol; 2006 Jul; 61(2):324-37. PubMed ID: 16856939
[TBL] [Abstract][Full Text] [Related]
13. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
14. Self-association of the transmembrane domain of an anthrax toxin receptor.
Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
[TBL] [Abstract][Full Text] [Related]
15. Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains.
Bot S; Andreuzzi E; Capuano A; Schiavinato A; Colombatti A; Doliana R
Matrix Biol; 2015 Jan; 41():44-55. PubMed ID: 25445627
[TBL] [Abstract][Full Text] [Related]
16. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
Dawson RM
J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
[TBL] [Abstract][Full Text] [Related]
17. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.
Pini A; Runci Y; Falciani C; Lelli B; Brunetti J; Pileri S; Fabbrini M; Lozzi L; Ricci C; Bernini A; Tonello F; Dal Molin F; Neri P; Niccolai N; Bracci L
Biochem J; 2006 Apr; 395(1):157-63. PubMed ID: 16398644
[TBL] [Abstract][Full Text] [Related]
18. A soluble receptor decoy protects rats against anthrax lethal toxin challenge.
Scobie HM; Thomas D; Marlett JM; Destito G; Wigelsworth DJ; Collier RJ; Young JA; Manchester M
J Infect Dis; 2005 Sep; 192(6):1047-51. PubMed ID: 16107958
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
[TBL] [Abstract][Full Text] [Related]
20. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli.
Chang HH; Tsai MF; Chung CP; Chen PK; Hu HI; Kau JH; Huang HH; Lin HC; Sun DS
J Biotechnol; 2006 Nov; 126(3):277-85. PubMed ID: 16797097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
